We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Neusoft Medical Systems

Neusoft Medical System’s range of medical products and services includes imaging equipment, e-hospital solutions, reg... read more Featured Products: More products

Download Mobile App





Neusoft Showcases NeuMR 1.5T Powered by AIM (Artificial Intelligent Management) at Arab Health 2020

By HospiMedica International staff writers
Posted on 30 Jan 2020
Neusoft Corporation (Shenyang, China) showcased its NeuMR 1.5T system at this year’s Arab Health (January 27 – 30, 2020) in Dubai, UAE. Based on profound MRI accumulation and cutting-edge artificial intelligence (AI) technology, the NeuMR 1.5T features AI-enabled management for the entire imaging chain, service and system efficiency.

NeuMR 1.5T provides AIM-StreamAID, AIM-SpeedAID and AIM-ImageAID in its entire imaging chain, while delivering robust, consistent and precise imaging. The AIM technology, supported by Neusoft’s unique and creative algorithm, computation power and big data, brings limitless space and more possibilities for MRI equipment. Value powered by AIM, the NeuMR 1.5T delivers fast routine examination, as well as precise and quantitative applications, such as BrainQuant, HDDWI&DTI, MRS, etc.

The NeuMR 1.5T is the first system of Neusoft’s next generation devices that follow a reduced and patient-focused design approach. Gently tapered surfaces serve to lessen the patient’s anxiety, while the clearly defined contours reflect the advanced technology used. Tactile, auditory and visual feedback enables human-machine interaction that gives the patient a sense of control during the examination and improves their cooperation.

Related Links:
Neusoft Corporation


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Anesthetic Gas Measurement Module
Scio Four
New
Mattress System
Apollo Infant Dynamic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Samples of heart tissue from the study (Photo courtesy of Nathan Gianneschi/Northwestern University)

New Potent Injectable Therapy Could Prevent Heart Failure After Heart Attack

According to the U.S. Centers for Disease Control and Prevention, 6.7 million Americans aged 20 and older are living with heart failure, a condition in which the heart cannot pump enough blood to meet... Read more

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.